| 2021 | TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation | Ho, JSY; Mok, BW; Campisi, L; Jordan, T; Yildiz, S; Parameswaran, S; Wayman, JA; Gaudreault, NN; Meekins, DA; Indran, SV; Morozov, I; Trujillo, JD; Fstkchyan, YS; Rathnasinghe, R; Zhu, Z; Zheng, S; Zhao, N; White, K; Ray-Jones, H; Malysheva, V; Thiecke, MJ; Lau, SY; Liu, H; Zhang, AJ; Lee, AC; Liu, WC ; Jangra, S; Escalera, A; Aydillo, T; Melo, BS; Guccione, E; Sebra, R; Shum, E; Bakker, J; Kaufman, DA; Moreira, AL; Carossino, M; Balasuriya, UBR; Byun, M; Albrecht, RA; Schotsaert, M; Garcia-Sastre, A; Chanda, SK; Miraldi, ER; Jeyasekharan, AD; TenOever, BR; Spivakov, M; Weirauch, MT; Heinz, S; Chen, H; Benner, C; Richt, JA; Marazzi, I | Cell 184(10), 2618-2632.e17 | | | |
